Format

Send to

Choose Destination
J Neurol. 2017 Nov;264(11):2224-2231. doi: 10.1007/s00415-017-8619-4. Epub 2017 Sep 15.

Comorbidity of dementia with amyotrophic lateral sclerosis (ALS): insights from a large multicenter Italian cohort.

Author information

1
Department of Medical, Surgical, Neurological, Metabolic and Aging Sciences, MRI Research Center SUN-FISM, University of Campania "Luigi Vanvitelli", Naples, Italy.
2
Department of Psychology, Università degli Studi della Campania "L. Vanvitelli", Naples, Italy.
3
NEuroMuscular Omnicentre (NEMO), Serena Onlus Foundation, Milan, Italy.
4
NEMO Sud Clinical Center for Neuromuscular Diseases, Aurora Onlus Foundation, Messina, Italy.
5
ALS Center, "Rita Levi Montalcini" Department of Neuroscience, University of Torino, Turin, Italy.
6
Department of Neurorehabilitation, ALS Center, IRCCS Scientific Clinical Institute Maugeri, Milan, Italy.
7
Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy.
8
Department of Pathophysiology and Transplantation, 'Dino Ferrari' Center, University of Milan, Milan, Italy.
9
Neurorehabilitation Unit/ALS Center, Scientific Clinical Institutes (ICS) Maugeri, IRCCS, Mistretta, Messina, Italy.
10
Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genova, IRCCS AOU San Martino-IST, Genoa, Italy.
11
Department of Neurosciences, Neuromuscular Center, University of Padova, Padua, Italy.
12
NEuroMuscular Omnicentre (NEMO), Serena Onlus Foundation, Pol. A. Gemelli Foundation, Rome, Italy.
13
Division of Neuroscience, Department of Neurology, Institute of Experimental Neurology (INSPE), San Raffaele Scientific Institute, Milan, Italy.
14
Department of Clinical Research in Neurology, University of Bari "A. Moro", at Pia Fondazione "Card. G. Panico", Tricase, Lecce, Italy.
15
Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
16
Department Biomedical Sciences for Health, University of Milan, Milan, Italy.
17
Department of Geriatrics, Neurosciences and Orthopedics, Institute of Neurology, Catholic University of Sacred Heart, Rome, Italy.
18
Department of Neuroscience, S. Agostino-Estense Hospital, University of Modena and Reggio Emilia, Modena, Italy.
19
Department of Medical, Surgical, Neurological, Metabolic and Aging Sciences, MRI Research Center SUN-FISM, University of Campania "Luigi Vanvitelli", Naples, Italy. gioacchino.tedeschi@unina2.it.

Abstract

To assess the association, at diagnosis, between amyotrophic lateral sclerosis (ALS) and dementia in a large cohort of well-characterized Italian patients. We investigated the phenotypic profile of 1638 incident patients with definite, probable or laboratory-supported probable ALS, diagnosed from January 2009 to December 2013 in 13 Italian Referral Centers, located in 10 Italian Regions, and classified in two independent subsamples accounting for presence or not of dementia. The collected ALS features, including survival and other follow-up data, were compared between the two subgroups using a one-way analysis of variance and Chi-square test, as appropriate, logistic regression models and Kaplan-Meier survival analysis. Between-subgroup comparisons showed an older age at clinical observation (p = .006), at onset and at diagnosis (p = .002) in demented versus non demented ALS patients. After adjustment for these variables, diagnosis of dementia was significantly associated with higher odds of family history of ALS (p = .001) and frontotemporal dementia (p = .003) and of bulbar onset (p = .004), and lower odds of flail leg phenotype (p = .019) and spinal onset (p = .008). The median survival time was shorter in demented versus non-demented patients, especially in case of classical, bulbar and flail limb phenotypes and both bulbar and spinal onset. Our multicenter study emphasized the importance of an early diagnosis of comorbid dementia in ALS patients, which may have clinical impact and prognostic relevance. Moreover, our results may give further inputs to validation of ALS-specific tools for the screening of cognitive impairment in clinical practice.

KEYWORDS:

Amyotrophic lateral sclerosis; Clinical phenotype; Dementia; Survival

PMID:
28914354
DOI:
10.1007/s00415-017-8619-4
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center